Search research articles
Contact Us
Filters
Showing results (141-150 of 167) with videos related to
Page
of 17
Sort By:
The Biochemical Journal
|
December 8, 1998
Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha
M Aoyama, D R Grabowski, G R Dubyak, et al.
Blood
|
October 9, 1998
Altered expression and activity of topoisomerases during all-trans retinoic acid-induced differentiation of HL-60 cells
M Aoyama, D R Grabowski, R J Isaacs, et al.
The Cancer Journal From Scientific American
|
February 24, 2000
Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape
P Rayman, R G Uzzo, V Kolenko, et al.
Cancer Research
|
March 15, 1993
T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors
J P Alexander, S Kudoh, K A Melsop, et al.
Cancer Treatment Reports
|
July 1, 1983
Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study
F R Ahmann, F L Meyskens, S E Jones, et al.
Cancer
|
November 1, 1993
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors
J E Janik, M Sznol, W J Urba, et al.
Cancer Research
|
February 1, 1991
Phase I trial of natural human interferon beta in metastatic malignancy
R M Bukowski, J S Sergi, W J Sharfman, et al.
The Journal of Clinical Investigation
|
September 24, 1999
Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells
R G Uzzo, P Rayman, V Kolenko, et al.
American Journal of Clinical Oncology
|
February 1, 1994
Adenocarcinoma of the esophagus and gastroesophageal junction. Clinical and pathologic assessment of response to induction chemotherapy
D J Adelstein, T W Rice, G A Boyce, et al.
Cancer Treatment Reports
|
December 1, 1987
Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study
N Oishi, J Berenberg, B A Blumenstein, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 167) with videos related to
Sort By:
Page
of 17
The Biochemical Journal
|
December 8, 1998
Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha
M Aoyama, D R Grabowski, G R Dubyak, et al.
Blood
|
October 9, 1998
Altered expression and activity of topoisomerases during all-trans retinoic acid-induced differentiation of HL-60 cells
M Aoyama, D R Grabowski, R J Isaacs, et al.
The Cancer Journal From Scientific American
|
February 24, 2000
Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape
P Rayman, R G Uzzo, V Kolenko, et al.
Cancer Research
|
March 15, 1993
T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors
J P Alexander, S Kudoh, K A Melsop, et al.
Cancer Treatment Reports
|
July 1, 1983
Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study
F R Ahmann, F L Meyskens, S E Jones, et al.
Cancer
|
November 1, 1993
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors
J E Janik, M Sznol, W J Urba, et al.
Cancer Research
|
February 1, 1991
Phase I trial of natural human interferon beta in metastatic malignancy
R M Bukowski, J S Sergi, W J Sharfman, et al.
The Journal of Clinical Investigation
|
September 24, 1999
Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells
R G Uzzo, P Rayman, V Kolenko, et al.
American Journal of Clinical Oncology
|
February 1, 1994
Adenocarcinoma of the esophagus and gastroesophageal junction. Clinical and pathologic assessment of response to induction chemotherapy
D J Adelstein, T W Rice, G A Boyce, et al.
Cancer Treatment Reports
|
December 1, 1987
Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study
N Oishi, J Berenberg, B A Blumenstein, et al.
Page
of 17